Serial changes in liquid biopsy-derived variant allele frequency predict immune checkpoint inhibitor responsiveness in the pan-cancer setting.
Kato S, Li B, Adashek JJ, Cha SW, Bianchi-Frias D, Qian D, Kim L, So TW, Mitchell M, Kamei N, Hoiness R, Hoo J, Gray PN, Iyama T, Kashiwagi M, Lu HM, Kurzrock R.
Kato S, et al. Among authors: hoo j.
Oncoimmunology. 2022 Mar 29;11(1):2052410. doi: 10.1080/2162402X.2022.2052410. eCollection 2022.
Oncoimmunology. 2022.
PMID: 35371621
Free PMC article.